SpotitEarly: Funding, Investors & Team (Oct 2026)
SpotitEarly provides a pre-screening test for multiple types of cancer using just one breath sample. This convenient and innovative method enables individuals to perform cancer screenings from the comfort of their own home. The test is able to accurately detect Breast, Lung, Colon, and Prostate cancers. By streamlining the detection process, SpotitEarly hopes to improve early diagnosis, which is vital for successful treatment. The company is dedicated to making cancer detection easier and less invasive, meeting the needs of both patients and healthcare professionals. Through its distinct approach, SpotitEarly plays a key role in advancing health management and early intervention tactics.
SpotitEarly has raised $20.4M across 3 funding rounds on record, the most recent an undisclosed round of $100k announced in Dec 2025.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SpotitEarly Company Profile and Key Stats
Latest funding round on record: Dec 2025.
SpotitEarly Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
SpotitEarly announced an undisclosed round in Jan 2025; the amount was not disclosed.
4 months later, an undisclosed round of $20.3M was announced in May 2025.
7 months later, an undisclosed round of $100k was announced in Dec 2025.
SpotitEarly Founders and Leadership Team
Contact details for the SpotitEarly team: 3 of 3 have an email address on file.
Start 14-day free trial →SpotitEarly Funding Compared to Other Biotechnology Startups
SpotitEarly's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SpotitEarly in Biotechnology and Englewood
Companies Similar to SpotitEarly
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
SpotitEarly Funding FAQs
What does SpotitEarly do?
SpotitEarly provides a pre-screening test for multiple types of cancer using just one breath sample. This convenient and innovative method enables individuals to perform cancer screenings from the comfort of their own home. The test is able to accurately detect Breast, Lung, Colon, and Prostate cancers. By streamlining the detection process, SpotitEarly hopes to improve early diagnosis, which is vital for successful treatment. The company is dedicated to making cancer detection easier and less invasive, meeting the needs of both patients and healthcare professionals. Through its distinct approach, SpotitEarly plays a key role in advancing health management and early intervention tactics.
How much funding has SpotitEarly raised?
SpotitEarly has raised $20.4M across 3 rounds on record. The most recent is an undisclosed round of $100k announced in Dec 2025.
When did SpotitEarly last raise funding?
SpotitEarly's most recent funding round on record is an undisclosed round of $100k, announced in Dec 2025.
Who founded SpotitEarly?
FundedIQ lists Ariel Ben Dayan (Founder), Ohad Sharon (Founder), Udi Bobrovsky (Founder) at SpotitEarly.
Where is SpotitEarly headquartered?
SpotitEarly is based in Englewood, New Jersey, United States.
How many employees does SpotitEarly have?
SpotitEarly is in the 11-50 employee band.
How does SpotitEarly's funding compare to other Biotechnology startups?
SpotitEarly's latest round of $100k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's SpotitEarly Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SpotitEarly is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.